Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Montauk Renewables Full Year 2025 Earnings Call - $200M Refinance Funds Turkey NC Launch, But RIN Weakness Squeezes EBITDA
Montauk closed 2025 with mixed operational progress and clear financial tradeoffs. RNG production growth came from expanded capacity at Pico and new processing at Apex, and the company has begun commi...
- Closed new senior credit facility with HASI in March 2026, up to $200 million, $155 million outstanding as of March 11, 2026; fixed interest rate 10.25%, maturity 2031, 24-month availability period and increased total net leverage covenant to 4.0x from 3.0x.
- Turkey, North Carolina project commissioning has started, first-phase capacity to process feedstock from ~400-450k hog spaces (≈35,000 tons annual waste), initial phase capex expected ≈ $200 million, commercial production expected to begin April 2026.
- RNG production showed site-level growth (Pico expansion produced ~31.8% more year-over-year; Apex second facility commissioned), company reported roughly 5.6 million MMBtu of RNG in 2025 (comparable to 2024 on a consolidated basis after asset sale adjustments).
- +11 more takeaways
Gambling.com Group Fourth Quarter 2025 Earnings Call - Data services surge offsets SEO hit
Gambling.com Group reported a record Q4 with revenue of $46.2 million, up 31% year-over-year, and adjusted EBITDA of $15.5 million, up 5% YoY. The call drew a sharp contrast between two businesses: a ...
- Q4 record revenue $46.2m, up 31% year-over-year, adjusted EBITDA $15.5m, up 5% YoY.
- Sports data services (OpticOdds/OddsJam/RotoWire) grew to $11.8m in Q4, up 440% YoY, and accounted for 26% of total revenue, the highest share to date.
- Full-year 2025 revenue $165m, up 30% YoY; full-year adjusted EBITDA up 19%; adjusted free cash flow for 2025 $36.3m.
- +14 more takeaways
Futu Holdings Fourth Quarter and Full Year 2025 Earnings Call - Client growth and margin expansion driven by overseas scale and product push
Futu closed 2025 with aggressive client and revenue momentum. Funded accounts reached about 3.4 million, up 40% year-over-year, after adding roughly 950,000 net new funded accounts in 2025, beating gu...
- Funded accounts reached approximately 3.4 million at year end, up 40% year-over-year after adding more than 950,000 net new funded accounts in 2025, 19% above guidance.
- Management guided to 800,000 net new funded accounts for 2026, the target includes entry into one additional new Asian market.
- Q4 net new funded accounts were ~230,000, down 8% quarter-over-quarter but up 9% year-over-year.
- +15 more takeaways
MariMed Inc. Fiscal Q4 2025 Earnings Call - Brand-led Wholesale Growth Offsets Price Pressure, EBITDA Remains Positive
MariMed closed fiscal 2025 with $159.8 million in revenue, roughly flat with 2024, and reported its sixth consecutive year of positive adjusted EBITDA at $16.9 million (10.5% margin). The story was no...
- Full-year 2025 revenue $159.8 million, roughly +1% vs 2024; Q4 revenue $41.7 million (1.3% sequential growth).
- Non-GAAP EBITDA $16.9 million for 2025, a 10.5% margin, down 12.8% year-over-year; this marks the sixth consecutive year of positive adjusted EBITDA.
- Wholesale revenue grew 11% in 2025 and now represents 44% of total company revenue, up from 40% in 2024. Wholesale is a deliberate growth vector.
- +13 more takeaways
Xunlei Limited Q4 and Fiscal Year 2025 Earnings Call - Pivot to overseas streaming and cloud divestiture fuels top-line surge, GAAP hit from Arashi Vision writedown
Xunlei closed 2025 with a sharp top-line move. Q4 revenue jumped to $143.3 million, up 70% year-over-year, and full-year revenue rose 42.5% to $462.4 million. Management points to subscription resilie...
- Total revenues for Q4 2025 were $143.3 million, a 70% year-over-year increase; full-year 2025 revenue was $462.4 million, up 42.5% versus 2024.
- Subscription revenue remains the stable core: Q4 subscription revenues were $42.1 million, up 22.4% year-over-year; full-year subscription revenue was $154.8 million, up 15.8%.
- Cloud computing staged a strong rebound: Q4 cloud revenue was $46.1 million, up 102.7% year-over-year; full-year cloud revenue was $137.4 million, up 31.4%.
- +12 more takeaways
Harvard Bioscience Q4 2025 Earnings Call - Strategic reset: refinancing, footprint consolidation, and pivot to translational science driving margin recovery
Harvard Bioscience closed 2025 with clear housekeeping done and a new playbook. Q4 revenue of $23.7 million beat the midpoint of guidance, gross margin hit roughly 60%, and adjusted EBITDA jumped 27% ...
- Q4 2025 revenue $23.7 million, slightly above the midpoint of guidance ($22.5M–$24.5M) and down from $24.6M in Q4 2024.
- Q4 gross margin of ~59.8% was at the high end of guidance and the highest in seven quarters, improving ~260 basis points year-over-year.
- Q4 adjusted EBITDA rose 27% year-over-year to $3.8 million; full year adjusted EBITDA increased 12.5% to $8.1 million.
- +12 more takeaways
Aurora Mobile Q4 2025 Earnings Call - First Full-Year GAAP Profit, EngageLab ARR Hits $10M
Aurora Mobile closed 2025 with a clean, unmistakable step up. Q4 revenue jumped to CNY 105.2 million, gross profit hit a 16-quarter high and the company delivered its first ever full-year GAAP net pro...
- Aurora Mobile reported Q4 revenue of CNY 105.2 million, up 13% year-over-year and 16% quarter-over-quarter.
- The company achieved its first full-year GAAP net profit in 2025, and this was the third consecutive profitable quarter.
- EngageLab ARR reached $10 million as of December 2025, a 186% year-over-year increase.
- +16 more takeaways
HERE Group Q2 FY2026 Earnings Call - Makuku-Led 39% Revenue Surge, Offline Push Narrows Margins
HERE reported a sharp quarter of top-line momentum after its shift to a pure-play IP company. Q2 revenue rose to RMB 177.3 million, up 39.4% sequentially, driven largely by flagship IP Makuku (RMB 139...
- Total revenue for Q2 FY2026 was RMB 177.3 million, a 39.4% sequential increase from RMB 127.1 million in Q1.
- Makuku is the dominant revenue driver, contributing RMB 139.4 million or about 73% of Q2 revenue.
- Fenono, launched July 2025, generated RMB 19.2 million in the quarter and is presented as a potential second flagship IP.
- +12 more takeaways
UiPath Q4 2026 Earnings Call - AI and agentic adoption stabilizes ARR, 30% long-term margin target set
UiPath told investors the story is now execution and scale, not theory. Management highlighted roughly $200 million of ARR traction in AI/agentic products, said net new ARR is stabilizing, and raised ...
- Management disclosed roughly $200 million of ARR traction from AI and agentic products, signaling early scale for the AI portfolio.
- UiPath raised its long-term non-GAAP operating margin target to 30 percent, with a multi-year timeframe of about three years and expectations that agentification will drive productivity.
- Net new ARR is described as stabilizing; FY27 guidance is deliberate and conservative, reflecting variability in the macro environment.
- +12 more takeaways
Biote Corp Q4 2025 Earnings Call - Investing to Expand Sales Force and Tech Despite Procedure Revenue Pressure
Biote closed 2025 with clear progress in rebuilding its commercial engine, but the business still shows the scars of elevated clinic attrition and lower procedure volumes. Q4 revenue fell to $46.4 mil...
- Q4 2025 revenue was $46.4 million, down 6.9% year over year.
- Procedure revenue declined 13% in Q4 to $31.8 million; procedure volume and net new clinic adds were the primary drivers.
- Dietary supplement revenue grew 16% to $11.7 million, led by e-commerce gains; supplements are forecast to grow mid- to high-single-digits in 2026.
- +12 more takeaways